公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2008 | Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link? | Hsu C.-S.; JIA-HORNG KAO | Hepatology | 0 | 0 | |
2006 | Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study | CHUN-JEN LIU ; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; CHI-LING CHEN ; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Hepatology | 41 | 35 | |
2013 | Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients | Hsu C.-S.; Huang C.-J.; JIA-HORNG KAO ; Lin H.H.; Chao Y.-C.; Fan Y.-C.; Tsai P.-S. | PLoS ONE | 34 | 29 | |
2007 | Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges | CHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO | Nephrology | 2 | 7 | |
2013 | Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan | Hsu C.-S.; JIA-HORNG KAO ; Chao Y.-C.; Lin H.H.; Fan Y.-C.; Huang C.-J.; Tsai P.-S. | Alimentary Pharmacology and Therapeutics | 101 | 99 | |
1999 | Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials | Schalm S.W.; Weiland O.; Hansen B.E.; Milella M.; Lai M.Y.; Hollander A.; Michielsen P.P.; Bellobuono A.; Chemello L.; Pastore G.; DING-SHINN CHEN ; Brouwer J.T.; Braconnier J.H.; Fryden A.; Norkrans G.; Reichard O.; Adler M.; Chamuleau R.A.F.M.; Delwaide J.; Elewaut A.; Fevery J.; Hautekeete M.L.; Nevens F.; Den Ouden-Muller J.W.; Wismans P.J.; Casalino C.; Maselli R.; Pietromatera G.; Chan K.W.; JIA-HORNG KAO ; Ideo G.; Alberti A.; Cavalletto L.; Boot J.; Van Vliet C. | Gastroenterology | 161 | 132 | |
2003 | Interferon-α reduces insulin resistance and β-cell secretion in responders among patients with chronic hepatitis B and C | TONG-YUAN TAI ; JIN-YING LU ; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; Lee, Cha-Ze ; Lee, Hsuan-Shu ; LEE-MING CHUANG ; YUNG-MING JENG | Journal of Endocrinology | 39 | 35 | |
2012 | Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy | CHEN-HUA LIU ; Liang C.-C.; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU ; SHIH-JER HSU ; JOU-WEI LIN ; Chen J.-H.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 40 | 39 | |
2012 | Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin | CHEN-HUA LIU ; Liang, Cheng-Chao; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Lin, Chih-Lin; Yang, Sheng-Shun; TUNG-HUNG SU ; JOU-WEI LIN ; Chen, Jun-Herng; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral therapy | 21 | 22 | |
2011 | Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives | CHEN-HUA LIU ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 6 | 6 | |
2024 | The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review | SHANG-CHIN HUANG ; JIA-HORNG KAO | The Kaohsiung journal of medical sciences | 1 | | |
1997 | Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virus | JIA-HORNG KAO ; CHUN-JEN LIU ; PEI-JER CHEN ; Chen W.; Hsiang S.-C.; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 34 | | |
2000 | Interspousal transmission of TT virus: Low efficiency and lack of apparent risk factors | CHUN-JEN LIU ; JIA-HORNG KAO ; Chen W.; Tsai R.-J.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 2 | 2 | |
2007 | Intrafamilial transmission of hepatitis B virus infection [3] | Lin C.-L.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 3 | 2 | |
1995 | Intrafamilial transmission of hepatitis C virus in hemodialysis patients | Hou C.-H.; Chen W.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN ; Yang Y.; Chen J.-J.; Lee S.-H.; Wu D.-J.; Yang S.-C. | Journal of Medical Virology | 42 | 33 | |
1992 | Intrafamilial Transmission of Hepatitis C Virus: The Important Role of Infections between Spouses | JIA-HORNG KAO ; PEI-JER CHEN ; PEI-MING YANG ; Lai M.-Y.; JIN-CHUAN SHEU ; Wang T.-H.; DING-SHINN CHEN | Journal of Infectious Diseases | 148 | 139 | |
2010 | Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm | JIA-HORNG KAO ; Chen S.L.; Ma H.I.; Law P.Y.; Tao P.L.; Loh H.H. | Journal of Pharmacology and Experimental Therapeutics | 20 | 20 | |
2021 | Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan | Lee W.-C.; Chen T.-K.; Han H.-F.; Lin Y.-C.; Hwang Y.-M.; JIA-HORNG KAO ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of Microbiology, Immunology and Infection | 2 | 2 | |
2021 | Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma | CHIH-HORNG WU ; PO-CHIN LIANG ; TUNG-HUNG SU ; Lin, Ming-Chi; Chang, Yu-Hsuan; TIFFANY TING-FANG SHIH ; JIA-HORNG KAO | Hepatology international | 8 | 7 | |
2006 | Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers | CHUN-JEN LIU ; JIA-HORNG KAO ; DING-SHINN CHEN | Gastroenterology | 7 | 7 | |